134 related articles for article (PubMed ID: 22692785)
21. Αnti-prion effects of anthocyanins.
Christoudia N; Bekas N; Kanata E; Chatziefsthathiou A; Pettas S; Karagianni K; Da Silva Correia SM; Schmitz M; Zerr I; Tsamesidis I; Xanthopoulos K; Dafou D; Sklaviadis T
Redox Biol; 2024 Jun; 72():103133. PubMed ID: 38565068
[TBL] [Abstract][Full Text] [Related]
22. Scrapie pathogenesis in subclinically infected B-cell-deficient mice.
Frigg R; Klein MA; Hegyi I; Zinkernagel RM; Aguzzi A
J Virol; 1999 Nov; 73(11):9584-8. PubMed ID: 10516067
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural studies of experimental scrapie and Creutzfeldt-Jakob disease in hamsters. I. Alterations of myelinated axons.
Liberski PP; Bratosiewicz-Wasik J; Gajdusek DC; Brown P
Acta Neurobiol Exp (Wars); 2002; 62(3):121-9. PubMed ID: 12416389
[TBL] [Abstract][Full Text] [Related]
24. The tubulovesicular structures - the ultrastructural hallmark for all prion diseases.
Liberski P
Acta Neurobiol Exp (Wars); 2008; 68(1):113-21. PubMed ID: 18389022
[TBL] [Abstract][Full Text] [Related]
25. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets.
Bieschke J; Giese A; Schulz-Schaeffer W; Zerr I; Poser S; Eigen M; Kretzschmar H
Proc Natl Acad Sci U S A; 2000 May; 97(10):5468-73. PubMed ID: 10805803
[TBL] [Abstract][Full Text] [Related]
26. Increased Gal-3 Mediates Microglia Activation and Neuroinflammation via the TREM2 Signaling Pathway in Prion Infection.
Fan Q; Wu YZ; Jia XX; A R; Liu CM; Zhang WW; Chao ZY; Zhou DH; Wang Y; Chen J; Xiao K; Chen C; Shi Q; Dong XP
ACS Chem Neurosci; 2023 Oct; 14(20):3772-3793. PubMed ID: 37769016
[TBL] [Abstract][Full Text] [Related]
27. Prion meeting 2023: implications of a growing field.
Outeiro TF; Vieira TCRG
Prion; 2024 Dec; 18(1):68-71. PubMed ID: 38651736
[TBL] [Abstract][Full Text] [Related]
28. In Vitro and In Vivo Evidence towards Fibronectin's Protective Effects against Prion Infection.
Garza MC; Kang SG; Kim C; Monleón E; van der Merwe J; Kramer DA; Fahlman R; Sim VL; Aiken J; McKenzie D; Cortez LM; Wille H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139358
[TBL] [Abstract][Full Text] [Related]
29. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
[TBL] [Abstract][Full Text] [Related]
30. Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity.
Smith JD; Nicholson EM; Foster GH; Greenlee JJ
BMC Vet Res; 2013 Jan; 9():8. PubMed ID: 23311930
[TBL] [Abstract][Full Text] [Related]
31. Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.
Tousseyn T; Bajsarowicz K; Sánchez H; Gheyara A; Oehler A; Geschwind M; DeArmond B; DeArmond SJ
J Neuropathol Exp Neurol; 2015 Sep; 74(9):873-88. PubMed ID: 26226132
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of ozone inactivation of infectious prion protein.
Ding N; Neumann NF; Price LM; Braithwaite SL; Balachandran A; Mitchell G; Belosevic M; Gamal El-Din M
Appl Environ Microbiol; 2013 Apr; 79(8):2721-30. PubMed ID: 23416994
[TBL] [Abstract][Full Text] [Related]
33. IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents.
Chen J; Chen C; Hu C; Liu L; Xia Y; Wang L; Yang W; Wu HY; Zhou W; Xiao K; Shi Q; Wu Y; Chen ZB; Dong XP
Virol Sin; 2020 Oct; 35(5):614-625. PubMed ID: 32314275
[TBL] [Abstract][Full Text] [Related]
34. Exuberant cellular reaction of the optic nerves in experimental Creutzfeldt-Jakob disease.
Liberski PP; Sikorska B; Bratosiewicz-Wasik J; Waliś A; Brown P; Brown D
Acta Neurobiol Exp (Wars); 2003; 63(4):309-18. PubMed ID: 15053254
[TBL] [Abstract][Full Text] [Related]
35. "Tubulofilamentous particles" are not scrapie-specific and are unrelated to tubulovesicular structures.
Liberski PP
Acta Neurobiol Exp (Wars); 1995; 55(3):149-54. PubMed ID: 8553908
[TBL] [Abstract][Full Text] [Related]
36. Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism.
Samra S; Sharma M; Vaseghi-Shanjani M; Del Bel KL; Byres L; Lin S; Dalmann J; Salman A; Mwenifumbo J; Modi BP; Biggs CM; Boelman C; Clarke LA; Lehman A; Turvey SE
HGG Adv; 2024 Jan; 5(1):100259. PubMed ID: 38041405
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural studies of experimental scrapie and Creutzfeldt-Jakob disease in hamsters. II. Astrocytic and macrophage reaction towards axonal destruction.
Liberski PP; Bratosiewicz-Wasik J; Gajdusek DC; Brown P
Acta Neurobiol Exp (Wars); 2002; 62(3):131-9. PubMed ID: 12416390
[TBL] [Abstract][Full Text] [Related]
38. Emergence of prions selectively resistant to combination drug therapy.
Burke CM; Mark KMK; Kun J; Beauchemin KS; Supattapone S
PLoS Pathog; 2020 May; 16(5):e1008581. PubMed ID: 32421750
[TBL] [Abstract][Full Text] [Related]
39.
Sultanakhmetov G; Limlingan SJM; Fukuchi A; Tsuda K; Suzuki H; Kato I; Saito T; Weitemier AZ; Ando K
Brain Commun; 2024; 6(3):fcae136. PubMed ID: 38712317
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic insights into the cure of prion disease by novel antiprion compounds.
Webb S; Lekishvili T; Loeschner C; Sellarajah S; Prelli F; Wisniewski T; Gilbert IH; Brown DR
J Virol; 2007 Oct; 81(19):10729-41. PubMed ID: 17652397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
